• Date: May 16, 2018

The above is the title of an article published in the Social Observatory of “la Caixa”, which shows imbalances between the social impact of certain diseases and the intensity of the research dedicated to them.

In Spain for example, illnesses such as strokes and depression are investigated less than they should be, given how frequently they occur in the population. Cardiovascular and infectious diseases cause considerable strain on healthcare systems around the world, but are the subject of less than 10% of scientific publications. The authors of the article also make a number of suggestions to try to adjust research efforts to the population's actual healthcare needs.

More news

July 24, 2018

The Spanish biotechnology sector received almost €150 million in 2017

These is one of the conclusions reached in the latest Annual Report published by the Spanish Association of Biotech Companies (ASEBIO).

July 12, 2018

Applications open for The Scientist's Top 10 Innovations 2018

The magazine The Scientist has spent a decade publishing the latest biomedicine innovations in its annual Top 10 Innovations contest. Applications are already open for this year’s competition.

July 05, 2018

Biocat launches a programme to find investors for early stage projects

The Investment Readiness Series is a new programme run by Biocat, offering mentoring and the chance to meet potential investors who are looking for healthcare research projects in the early stages of the innovation process.